open access publication

Article, 2024

Anticoagulation in atrial fibrillation. A large real-world update

EUROPEAN JOURNAL OF INTERNAL MEDICINE, ISSN 0953-6205, 0953-6205, Volume 121, Pages 88-94, 10.1016/j.ejim.2023.10.010

Contributors

Bo, Mario [1] [2] Fumagalli, Stefano 0000-0003-3598-6263 (Corresponding author) [3] Degli Esposti, Luca [4] Perrone, Valentina [4] Dovizio, Melania [4] Poli, Daniela 0000-0002-5166-6596 [3] Marcucci, Rossella [3] Verdecchia, Paolo 0000-0002-4135-8936 [5] Reboldi, Gianpaolo [6] Lip, Gregory Y. H. [7] [8] [9] [10] Ungar, Andrea 0000-0002-8965-4523 [3] Boccanelli, Alessandro [11] Fumagalli, Carlo 0000-0001-7963-5049 [3] [12] Marchionni, Niccolo 0000-0002-8101-4695 [3] Italian Soc Geriatric Cardiology

Affiliations

  1. [1] Univ Turin, Dept Med Sci, Sect Geriatr, AOU Citta Salute & Sci, Turin, Italy
  2. [NORA names: Italy; Europe, EU; OECD];
  3. [2] Univ Turin, Dept Med Sci, Sect Geriatr, AOU Citta Salute & Sci, Turin, Italy
  4. [NORA names: Italy; Europe, EU; OECD];
  5. [3] Univ Florence, Dept Expt & Clin Med, Largo G Brambilla 3, I-50134 Florence, Italy
  6. [NORA names: Italy; Europe, EU; OECD];
  7. [4] CliCon Soc Benefit Srl, Hlth Econ & Outcome Res, Bologna, Italy
  8. [NORA names: Italy; Europe, EU; OECD];
  9. [5] Osped S Maria Misericordia, Fdn Umbra Cuore & Ipertens ONLUS & Struttura Comp, Perugia, Italy
  10. [NORA names: Italy; Europe, EU; OECD];

Abstract

Conclusions: Beyond confirming the association with a better net clinical benefit of DOACs over VKAs, our findings substantiate the large proportion of NVAF patients still inappropriately anticoagulated, thereby reinforcing the need for educational programs.

Keywords

Aspirin, Atrial fibrillation, Direct oral anticoagulants, Real-world, Vitamin K antagonists

Data Provider: Clarivate